Skip to content

JNJ

JOHNSON & JOHNSON

NYSE · Healthcare · Drug Manufacturers - General · US

$275.20
+1.53%
Ask drillr

Income statement

MetricTTM2025202420232023
Revenue
Total Revenue99.3B94.2B88.8B85.2B80.0B
Cost of Revenue31.0B30.3B27.5B26.6B24.6B
Gross Profit68.4B63.9B61.4B58.6B55.4B
Operating Expenses
R&D Expense16.1B14.7B17.2B15.1B14.1B
SG&A Expense25.5B23.7B22.0B20.1B20.2B
General & Admin Expense——22.0B20.1B20.2B
Selling & Marketing Expense—————
Other Expenses1.2B————
Total Operating Expenses42.8B38.3B39.2B35.2B34.4B
Cost and Expenses73.8B68.6B66.7B61.8B59.0B
Operating Income (EBIT)25.5B25.6B22.1B23.4B21.0B
Non-Operating
Interest Income685.0M1.1B1.3B1.3B490.0M
Interest Expense798.0M971.0M755.0M772.0M276.0M
Net Interest Income(113.0M)85.0M577.0M489.0M214.0M
Other Non-Op Income/Expense(7.8B)7.0B(5.5B)(8.3B)(1.7B)
Non-Operating Income (excl Interest)690.0M(8.0B)4.7B7.6B1.4B
EBT (Pre-Tax Income)17.7B32.6B16.7B15.1B19.4B
Income Tax Expense1.6B5.8B2.6B1.7B3.0B
Bottom Line
Net Income16.1B26.8B14.1B35.2B17.9B
Earnings from Cont. Ops16.1B26.8B14.1B13.3B16.4B
Earnings from Discont. Ops———21.8B1.6B
Bottom Line Net Income16.1B26.8B14.1B35.2B17.9B
Per Share
Basic EPS$6.60$11.03$5.84$13.88$6.83
Diluted EPS$6.60$11.03$5.79$13.72$6.73
Revenue Per Share$40.59$38.78$36.90$33.61$30.61
Shares
Basic Shares Outstanding2.4B2.4B2.4B2.5B2.6B
Diluted Shares Outstanding2.4B2.4B2.4B2.6B2.7B
Profitability Metrics
EBITDA30.8B41.1B24.8B23.3B26.6B
D&A6.0B7.5B7.3B7.5B7.0B
EBIT24.8B33.6B17.4B15.8B19.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026